| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Physiology, School of Medicine, University of Occupational and Environmental Health (R.S., Y.U., M.N., Y.Y., I.S., H.Y.), Kitakyushu 807-8555; the Department of Foods and Human Nutrition, Faculty of Human Life Sciences, Notre Dame Seishin University (Y.Har., Y.Hat.), Okayama 700-8516; the First Department of Internal Medicine, Miyazaki Medical College (K.Ki.), Kihara Kiyotake, Miyazaki 889-1601; and the National Cardiovascular Center Research Institute (K.Ka.), Fujishirodai, Suita, Osaka 565-0873, Japan; and the Department of Physiology, University Medical School (J.A.R.), Edinburgh, United Kingdom EH8 9AG
Address all correspondence and requests for reprints to: Hiroshi Yamashita, M.D., Ph.D., Department of Physiology, University of Occupational and Environmental Health School of Medicine, 11 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. E-mail: yama{at}med uoeh.-u.ac.jp.
The effects of intracerebroventricular (icv) administration of adrenomedullin (AM) on plasma oxytocin (OXT), c-Fos protein (Fos), and c-fos messenger RNA (mRNA) in the paraventricular (PVN) and supraoptic nuclei (SON) of the rat were investigated using RIA for OXT, immunohistochemistry for Fos, and in situ hybridization histochemistry for c-Fos mRNA. Central administration of AM caused a significant increase in the plasma OXT level. Intracerebroventricular administration of AM caused a marked induction of Fos-like immunoreactivity (LI) in the PVN and in the dorsal parts of the SON. In the PVN and SON, OXT-LI cells predominantly exhibited nuclear Fos-LI in comparison with arginine vasopressin-LI cells. In situ hybridization histochemistry revealed that the induction of c-fos mRNA in the PVN and SON was increased in a dose-related manner 30 min after icv administration of AM. This induction was reduced by pretreatment with the AM receptor antagonist, human AM-(2252)-NH2. These results suggest that central AM is responsible for activating the neurosecretory cells in the PVN and SON via selective AM receptors, and that AM stimulates the secretion of OXT by activating hypothalamic OXT-producing cells.
This article has been cited by other articles:
![]() |
M. Kawasaki, T. Onaka, M. Nakazato, J. Saito, T. Mera, H. Hashimoto, H. Fujihara, N. Okimoto, H. Ohnishi, T. Nakamura, et al. Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats. J. Endocrinol., August 1, 2006; 190(2): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hashimoto, S. Hyodo, M. Kawasaki, T. Mera, L. Chen, A. Soya, T. Saito, H. Fujihara, T. Higuchi, Y. Takei, et al. Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E753 - E761. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Taylor, J. R. Baker, and W. K. Samson Brain-derived adrenomedullin controls blood volume through the regulation of arginine vasopressin production and release Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1203 - R1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ozaki, T. Onaka, M. Nakazato, J. Saito, K. Kanemoto, T. Matsumoto, and Y. Ueta Centrally Administered Neuromedin U Activates Neurosecretion and Induction of c-fos Messenger Ribonucleic Acid in the Paraventricular and Supraoptic Nuclei of Rat Endocrinology, November 1, 2002; 143(11): 4320 - 4329. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |